National Security Commission on Emerging Biotechnology
The National Security Commission on Emerging Biotechnology (NSCEB) is an American bipartisan legislative commission created by Congress in the National Defense Authorization Act for Fiscal Year 2022 (Sec. 1091).[1]
The National Security Commission on Emerging Biotechnology is charged with conducting a thorough review of how advances in emerging biotechnology and related technologies will shape current and future activities of the U.S. Department of Defense, providing an interim report to the President of the United States and the Armed Services Committees within one year, and submitting a final unclassified report within two years to the President and the committees, including recommendations for action by Congress and the federal government.[2]
The National Security Commission on Emerging Biotechnology was announced in March 2022 and will issue a final report to Congress by 2026.[3]
Commissioners
editThe NSCEB is composed of 12 appointed commissioners:
- Dr. Jason Kelly, Chair - Co-Founder and CEO of Ginkgo Bioworks[4][5]
- Dr. Michelle Rozo, Vice Chair [6]
- Senator Alex Padilla (D-CA)[7]
- Senator Todd Young (R-IN)[8]
- Representative Stephanie Bice (R-OK)[9]
- Representative Ro Khanna (D-CA)[10]
- The Honorable Dov S. Zakheim - former Under Secretary of Defense (Comptroller)[11]
- Mr. Paul Arcangeli[2]
- Dr. Alexander Titus - former Assistant Director for Biotechnology in the Office of the Under Secretary of Defense for Research and Engineering[12]
- Dr. Eric Schmidt - Billionaire philanthropist and former CEO of Google
- Dr. Angela Belcher[6]
- Ms. Dawn Meyerriecks [13]
Reports
editThe Commission submitted its first report to Congress in December 2023[14] which included policy recommendations related to agricultural policy for potential inclusion in the Farm Bill.[15]
In January 2024, the Commission released white papers regarding the convergence of artificial intelligence and biotechnology, or "AIxBio."[16]
References
edit- ^ "Statement by the President on S. 1605, the National Defense Authorization Act for Fiscal Year 2022". 27 December 2021.
- ^ a b "Armed Services Committees Leadership Announces Selections for National Security Commission on Emerging Biotechnology | United States Committee on Armed Services". www.armed-services.senate.gov. Retrieved 2022-03-19.
- ^ https://www.biotech.senate.gov/
- ^ "Jason Kelly | 2020 40 under 40 in Health". Fortune. Retrieved 2022-03-19.
- ^ Kelly, Jason (2021-12-15). "Ginkgo Welcomes Congress's Vote to Establish National Security Commission on Emerging Biotechnology". Ginkgo Bioworks. Retrieved 2022-03-19.
- ^ a b https://www.armed-services.senate.gov/press-releases/armed-services-committees-leadership-announces-chair-and-vice-chair-selections-for-national-security-commission-on-emerging-biotechnology
- ^ "Lawmakers name appointees to new emerging biotech panel | InsideDefense.com". insidedefense.com. Retrieved 2022-03-19.
- ^ "Young Named to National Security Commission on Emerging Biotechnology | U.S. Senator Todd Young of Indiana". www.young.senate.gov. Retrieved 2022-03-19.
- ^ "Bice Selected for National Security Commission on Emerging Biotechnology". Representative Stephanie Bice. 2022-03-17. Retrieved 2022-03-19.
- ^ "Indian-American Ro Khanna named to emerging biotechnology body". The American Bazaar. 2022-03-18. Retrieved 2022-03-19.
- ^ "The Hon. Dov S. Zakheim - Foreign Policy Research Institute". www.fpri.org. Retrieved 2022-03-19.
- ^ Cumbers, John. ""With Great Power Comes Great Responsibility" — Meet Alexander Titus The Department Of Defense's Head Of Biotechnology". Forbes. Retrieved 2022-03-19.
- ^ https://www.biotech.senate.gov/bio-dawn-meyerriecks/
- ^ "December 2023 New Report". Biotech. Retrieved 2024-01-19.
- ^ "New Biotech Commission Issues Interim Report". AIP. 2024-01-16. Retrieved 2024-02-01.
- ^ "AIxBio White Paper 1: Introduction to AI and Biotech". Biotech. Retrieved 2024-01-27.